arrow
M

Matthew S. Waitkus

Duke University School of Medicine
H指数:19
被引数:1,558

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use alternative lengthening of telomeres

SMARCAL1是ATRX缺陷型胶质瘤中一种可靶向的合成致死治疗弱点,该胶质瘤使用端粒替代性延长机制

2026-02-010
PRE
Multi-omic spatial analysis of the tumor microenvironment in gliomas
2024-03-220
PRE
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
2024-01-256
OAAI
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells

癌症相关的SMARCAL1功能丧失突变促进端粒酶阴性胶质母细胞瘤细胞中端粒的替代延长和肿瘤发生

2023-01-237
OA
The integrated genomic and epigenomic landscape of brainstem glioma
2020-06-1745
OAAI